Adalimumab에 의한 고리육아종Granuloma Annulare Induced by Adalimumab
- Other Titles
- Granuloma Annulare Induced by Adalimumab
- Authors
- 오영재; 최원준; 고주연; 노영석
- Issue Date
- 2011
- Publisher
- 대한피부과학회
- Keywords
- Adalimumab; Granuloma annulare; TNF-α inhibitor
- Citation
- Korean Journal of Dermatology, v.49, no.07, pp.656 - 659
- Indexed
- SCOPUS
KCI
- Journal Title
- Korean Journal of Dermatology
- Volume
- 49
- Number
- 07
- Start Page
- 656
- End Page
- 659
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/169381
- ISSN
- 0494-4739
- Abstract
- Adalimumab is the first fully humanized monoclonal anti-tumor necrosis factor alpha (TNF-α) antibody. This drug has been shown to be of benefit in patients with inflammatory diseases in which TNF-α is involved, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn’s disease. As the use of adalimumab is becoming more widespread, cutaneous side effects are being increasingly reported. Various dermatologic adverse events have been reported in the literature, including injection site reactions, psoriasis-like eruption and pityriasis rosea. Herein, we describe a case of GA associated with adalimumab treatment for adult-onset Still’s disease, which has not been reported in Korea.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 피부과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/169381)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.